Bioequivalence of An Oral Mercaptopurine Suspension 100 Mg / 5 Ml Versus Tablet in Healthy Male Subjects Under Fasting Conditions
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Acute Lymphoblastic Leukemia
Related studies linked through entity extraction aliases.
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor
- Status
- COMPLETED
- Phase
- PHASE2
Cardiometabolic Status in Childhood Acute Lymphoblastic Leukemia
- Status
- WITHDRAWN
- Phase
- N/A
Busulfan and Cyclophosphamide Followed By ALLO BMT
- Status
- TERMINATED
- Phase
- NA
Study of Fc-Optimized Anti-CD19 Antibody (MOR00208) to Treat B-cell Acute Lymphoblastic Leukemia(B-ALL)
- Status
- TERMINATED
- Phase
- PHASE2
A Phase 1, Open-Label, Dose-Escalation & Expanded Cohort, Continuous IV Infusion, Multi-center Study of the Safety, Tolerability,PK & PD of EPZ-5676 in Treatment Relapsed/Refractory Patients With Leukemias Involving
- Status
- COMPLETED
- Phase
- PHASE1
Pharmacogenetically Based Dosing of Thiopurines in Childhood Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- N/A
Clofarabine, Cyclophosphamide and Etoposide for Minimal Residual Disease Positive Acute Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE2
Steroid-Induced Osteoporosis in the Pediatric Population - Canadian Incidence Study
- Status
- COMPLETED
- Phase
- N/A
Busulfan/Clofarabine + Allogeneic Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Front-line Ponatinib in Adult Philadelphia+/BCR-ABL+ Acute Lymphoblastic Leukemia.
- Status
- COMPLETED
- Phase
- PHASE2
T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant
- Status
- TERMINATED
- Phase
- PHASE2
Donor-Derived Humoral Immunity, Hematopoietic Stem Cell Transplantation, TAR
- Status
- COMPLETED
- Phase
- NA
Liposomal Cytarabine in the Treatment of Central Nervous System Resistant or Relapsed Acute Lymphoblastic Leukemia in Children
- Status
- UNKNOWN
- Phase
- PHASE2
SC-PEG Asparaginase vs. Oncaspar in Pediatric Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma Gait Parameters Study
- Status
- COMPLETED
- Phase
- N/A
A Study Of Inotuzumab Ozogamicin Versus Investigator's Choice Of Chemotherapy In Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
Pharmacogenetic Analysis of Korean Pediatric Patients With Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- N/A
Treatment of Acute Lymphoblastic Leukemia HIGH RISK BCR / ABL NEGATIVE IN ADULTS
- Status
- COMPLETED
- Phase
- N/A